◀ Back to BCL6

BCL6 — CDK1

Text-mined interactions from Literome

Schmitt et al., Oncogene 2007 : Bcl-xL potently inhibits cdk1 ( cdc2 ) kinase activity, which is reversible by a synthetic peptide between the 41st amino acid and 60th amino acid surrounding of the Thr47 and Ser62 phosphorylation sites, and Asn52 deamidation site, within the flexible loop domain of bcl-xL
Ibrado et al., Leukemia 1998 : These findings indicate that Bcl-xL overexpression does not affect Taxol induced CDK1 activity leading to G2/M transition, which temporally precedes the cytosolic cyt c-mediated cleavage and activity of caspase-3 and apoptosis